Nanobac Pharmaceuticals Inc. to Present at the Fall Life Sciences
Conference in New York Premier Event to Be Held November 1st

NNBP  today announced that it has been invited to present at Friedland
Investment Events' Life Sciences Conference in New York. The
Conference will be held November 1st at the DoubleTree Hotel Times
Square, 1568 Broadway (47th / 7th), New York.

The Life Sciences Conference will feature presentations by senior
management of publicly traded companies in the biotech, healthcare,
medical devices and pharmaceutical industries.

Senior management of Nanobac's presentation will include a review of
current operations, and most importantly the company's plans for the
future.

Commenting on the company's participation at the conference, Dr.
Benedict Maniscalco, Nanobac's Chief Medical Officer stated, "Nanobac
is enthusiastic that our participation and presentation at the Life
Sciences Conference in New York will provide the opportunity to update
select and invited representatives of buy-side and sell-side firms
regarding the company, and most importantly, our plans for the
future."
Nanobac Pharmaceuticals Inc. is headquartered in Tampa, Florida. For
more information, visit our website at: http://www.nanobac.com
.
About Friedland Investment Events
Friedland Investment Events LLC, the sponsor of the Global Equities
Conference, is the world's largest sponsor of financial and investment
events, sponsoring hundreds of conferences, luncheons, dinner,
cocktail receptions and road shows annually throughout the United
States.